UNSPSC 51144109: Amphetamine phosphate

This classification denotes a cns stimulant with the molecular formula C9H13N.H3O4P, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 163DO59R3J. European Medicines Agency schedules amfetamine phosphate in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB36020. Most nations, for tariff and trade purposes, schedule amphetamine phosphate under HS 29214600. As of Q4 2014, AMPHETAMINE PHOSPHATE remains US FDA's Preferred Term for this commodity. SMILES: CC(CC1CCCCC1)N.OP(=O)(O)O.

UNSPSC 51144109 Amphetamine phosphate is a Commodity code that in recent state and local procurement activity covers the supply of controlled and non-controlled pharmaceuticals, OTC products, and harm-reduction medical supplies rather than amphetamine compounds specifically. State and local governments procuring under this code are sourcing naloxone kits, safe drug deactivation systems, generic multi-source pharmaceuticals, and OTC products to support public health, community safety, and employee health benefit programs. The issuing bodies span county health departments, state health and human services agencies, and multi-state cooperative purchasing alliances serving multiple state and local jurisdictions.

Recent activity includes Seminole County, Florida's IFB for 1,900 units of naloxone and 800 safe drug deactivation systems annually (IFB60459723LAS, due July 26, 2023, with quarterly deliveries to the Seminole County Community Health Building); the Texas Health and Human Services Commission's Request for Information on direct-to-manufacturer prescription programs (RFI HHS0017013, posted April 3, 2026) to evaluate vendor capacity for state pharmacy benefit contracting outside traditional pharmacy benefit manager channels; and the Minnesota Multistate Cooperative Purchasing Alliance's RFP for generic multi-source pharmaceuticals and OTC products serving participating state and local facilities across Minnesota and Oregon (S1070000015802, due March 26, 2026, with contract effective July 1, 2026). Geographic activity centers on Florida, Texas, and Minnesota with multi-state reach through cooperative purchasing vehicles. The code shows mixed recent activity, with issuing bodies requiring compliance with DEA regulations, cGMP certification, Drug Supply Chain Security Act adherence, and E-Verify employment verification, and contracts typically structured with two-year initial terms and optional renewals.